Creative Medical Technology Holdings
Creative Medical Technology Holdings

Creative Medical Technology Holdings

Biotechnology
WebsiteInvestor RelationsSEC
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.

$5.4M

Market Cap • 10/15/2026

1998

(28 years)

Founded

2009

(17 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

0,6

P/S

1797,1

P/EBITDA

—

P/OCF

—

P/FCF

—

P/E

—

BVPS

1,3

EPS

—

Market Cap

Market Cap

5,4M

EV

-3,4M

EV/Revenue

-1136,5

EV/EBITDA

0,6

EV/EBIT

0,5

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

0%

Total Yield

0%

Payout

0%

Retained Earnings

-73,5M

Profitability

Gross Margin

66,9%

EBITDA Margin

—

EBIT Margin

—

Net Margin

—

D&A/EBITDA

0%

R&D/Revenue

67203%

Capex/Revenue

0%

Capex/D&A

0%

Capex/OCF

0%

SBC/OCF

—

% PPE

0%

% Goodwill

0%

ROE

—

ROIC

—

Growth

CAGR Revenue 5Y

-50,8%

CAGR Op. Income 5Y

35,1%

CAGR Net Income 5Y

-14,6%

CAGR EPS 5Y

-67,5%

CAGR OCF 5Y

68,5%

Leverage

N.D./EBITDA

1,4

Debt/Equity

0%

Current Ratio

12,9

Quick Ratio

12,8

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium